Novo Nordisk’s Wegovy Shows Weight Loss-Independent Liver Benefits in MASH Trial Data

Novo Nordisk (NYSE:NVO) is one of the most profitable large cap stocks to buy right now. On November 10, Novo Nordisk ...
Houston Public Media

5 things to know about the new obesity pills that are on the way

Instead of struggling with weekly injections, patients may soon be able to swallow a daily pill to lose weight. Both the ...

There’s still hope GLP-1 drugs could slow the second-biggest type of dementia

Vascular dementia is the second-most common form of dementia after Alzheimer’s. About 2.7 million people in the U.S. are thought to have mixed dementia or vascular dementia, which is caused by strokes ...